Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Boston Scientific Announces Fourth Deal in 2018

Boston Scientific Announces Fourth Deal in 2018

by | Jul 6, 2018 11:36 am | Medical Devices

In a quiet holiday week, Boston Scientific Corporation (NYSE: BSX) made some news with its $202 million acquisition of privately held Criterion Medical, Inc. Founded in 2016, Criterion Medical has developed a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). Boston Scientific already held a 35% stake in the Carlsbad, California-based company. The $202 million paid for the 65% it didn’t already own. The addition of this cryoballoon platform positions Boston Scientific as the first to have both cryothermal and radiofrequency (RF) single-shot, balloon-based ablation therapies in its portfolio. This is Boston Scientific’s fourth announced acquisition... Read More »
LifeScan Diabetes Deal Brings $2.1 Billion

LifeScan Diabetes Deal Brings $2.1 Billion

by | Jun 14, 2018 9:57 am | Medical Devices, Private Equity

Johnson & Johnson’s (NYSE: JNJ) selling spree continued with the divestiture of LifeScan, Inc. for $2.1 billion. LifeScan is a leader in blood glucose monitoring products, serving approximately 20 million patients globally in more than 90 countries. LifeScan markets blood glucose monitoring systems for home and hospital use under the global brand, One Touch. The OneTouch portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The buyer, Platinum Equity, made its offer in March 2018 after working with J&J to craft a deal to allow LifeScan to beome a standalone business that would continue to... Read More »
Boston Scientific Announces Fourth Deal in 2018

Ethicon Sells Its Advanced Sterilization Products for $2.7 Billion

by | Jun 11, 2018 9:19 am | Medical Devices

Johnson & Johnson (NYSE: JNJ) subsidiary Ethicon last week sold its advanced sterilization products (ASP) business to Fortive Corporation (NYSE: FTV) for $2.7 billion. The ASP business is a global provider of innovative sterilization and disinfection solutions. It generated adjusted EBITDA margin of approximately 25% (unaudited) in 2017. Fortive is a diversified industrial growth company comprised of professional instrumentation and industrial technologies businesses. Fortive’s brands generated revenue of $6.7 billion in 2017. ASP’s products include the STERRAD system for sterilizing instruments and the EVOTECH and ENDOCLENS system for endoscope reprocessing and cleaning.... Read More »
MedPlast Adds Integer’s Surgical and Orthopedics Lines

MedPlast Adds Integer’s Surgical and Orthopedics Lines

by | May 31, 2018 11:16 am | Medical Devices

MedPlast Inc., a portfolio company of JLL Partners and Water Street Healthcare Partners, announced the largest deal in the Medical Device sector in May 2018. The company, which provides integrated custom plastic processing solutions for finished medical devices, acquired the advanced surgical and orthopedics lines (ASO) from Integer (NYSE: ITGR) for $600 million. The transaction includes 10 manufacturing facilities. The ASO business comprises products and services for the laparoscopy, general surgery, biopsy and drug delivery, arthroscopic devices and components and orthopedic markets. Integer, formerly known as Greatbatch, rebranded in 2016 under the Integer name. With this acquisition,... Read More »
ResMed Adds HealthCareFirst to Home Health Solutions

ResMed Adds HealthCareFirst to Home Health Solutions

by | May 29, 2018 4:48 pm | eHealth, Home Health & Hospice, Medical Devices

Medical device maker ResMed (NYSE: RMD) is moving deeper into the Home Health & Hospice arena. The company announced its acquisition of HealthCareFirst, which provides software solutions for home health and hospice agencies. HealthCareFirst offers electronic health record (EHR) software, billing and coding services, and advanced analytics to help agencies optimize their clinical, financial and administrative processes. Financial terms were not disclosed. Pamlico Capital is the seller, having acquired HealthCareFirst in September 2012 from The Riverside Company. ResMed’s devices and software solutions help to treat and manage sleep apnea, chronic obstructive pulmonary disease... Read More »
ResMed Adds HealthCareFirst to Home Health Solutions

Sleep Disorders Make for Steady Business

by | Apr 13, 2018 11:26 am | eHealth, Medical Devices

For all the companies and remedies devoted to sleep disorders, it’s a wonder they haven’t been cured by now. The latest deal targeting a company focused on sleep apnea and other conditions was announced last week, on April 11. SleepScore Labs, a medical device company based in Carlsbad, California, acquired the Dutch technology company Sleep.ai for an undisclosed amount. SleepScore Labs was founded in 2016 and is a joint venture between Dr. Mehmet Oz, ResMed (NYSE: RMD) and Pegasus Capital Advisors. It is focused on improving sleep and uses ResMed’s SleepScore technology. ResMed specializes in cloud-connected devices for daily remote patient monitoring, to help treat and... Read More »